Skip to content
JCP
PCC
Insights
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
Insights
About
Authors & Reviewers
Sign In
Subscribe
Sign in
Subscribe
Clinical Topics
View All
Addiction
ADHD
Alzheimer’s Disease
Anxiety
Bipolar Disorder
Depression
Movement Disorders
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia/Schizoaffective Disorders
Sleep
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Evolving Psychedelic Paradigm
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
JCP Podcast
Rounds in the General Hospital
View All
Daniel L. C. Costa, MD, PhD
JCP
Original Research
N
-Acetylcysteine Augmentation for Treatment-Resistant OCD
August 23, 2017
About half of OCD patients treated with an adequate trial of serotonin reuptake inhibitors (SRIs) fail to fully respond to treatment. This randomized controlled trial examined whether N-acetylcysteine, a...
Christopher Pittenger
,
Michael H. Bloch
,
Juliana B. Diniz
, et al
JCP
Letter to the Editor
Considering the Complexity of Treatment Response in Psychiatric Clinical Trials
December 28, 2016
Juliana Belo Diniz
,
Roseli Gedanke Shavitt
,
Eurípedes Constantino Miguel
, et al
